Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-22 3:47 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Logos Global Management LP | 15,000,000 7.2% | 15,000,000 (New Position) | View |
| 2024-02-15 4:17 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | TCG Crossover GP II LLC | 20,763,572 9.9% | 20,763,572 (New Position) | View |
| 2024-02-14 8:26 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Venrock Healthcare Capital Partners III L.P. | 15,564,213 7.5% | 9,664,724 (+163.82%) | View |
| 2024-02-14 4:30 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Vivo Opportunity Fund Holdings L.P. | 15,000,000 7.2% | 15,000,000 (New Position) | View |
| 2024-02-14 4:05 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | COMMODORE CAPITAL LP | 10,000,000 9.9% | 3,841,859 (+62.39%) | View |
| 2024-02-13 7:34 pm Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BANK OF AMERICA CORP BAC | 4,425,895 4.4% | -1,166,001 (-20.85%) | View |
| 2024-02-12 10:13 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | MORGAN STANLEY MS | 5,150,496 5.1% | -1,984,556 (-27.81%) | View |
| 2024-02-09 11:41 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Frazier Life Sciences Public Fund L.P. | 10,416,666 11% | 10,416,666 (New Position) | View |
| 2024-02-09 08:35 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | FMR LLC | 6,124,272 6.062% | -1,648,602 (-21.21%) | View |
| 2024-02-07 11:36 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 4,854,252 2.3% | -2,445,927 (-33.51%) | View |
| 2023-07-24 4:16 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Venrock Healthcare Capital Partners III L.P. | 5,899,489 5.9% | 5,899,489 (New Position) | View |
| 2023-04-20 4:05 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | COMMODORE CAPITAL LP | 6,158,141 6.1% | 6,158,141 (New Position) | View |
| 2023-02-14 10:20 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RTW INVESTMENTS LP | 0 0% | -7,554,817 (Position Closed) | View |
| 2023-02-14 09:30 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Avoro Capital Advisors LLC | 0 0% | -6,950,000 (Position Closed) | View |
| 2023-02-14 08:06 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Soleus Capital Master Fund L.P. | 0 0% | -4,982,789 (Position Closed) | View |
| 2023-02-14 07:55 am Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BANK OF AMERICA CORP BAC | 5,591,896 5.6% | 5,591,896 (New Position) | View |
| 2023-02-09 08:23 am Sale | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | FMR LLC | 7,772,874 7.793% | -3,100,979 (-28.52%) | View |
| 2023-02-08 4:44 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 7,300,179 7.3% | 2,124,679 (+41.05%) | View |
| 2023-02-08 2:48 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | MORGAN STANLEY MS | 7,135,052 7.2% | 7,135,052 (New Position) | View |
| 2022-12-30 4:11 pm Sale | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 4,631,432 4.6% | -2,000,000 (-30.16%) | View |